NEXGEL, INC. Cash and Cash Equivalents
NEXGEL, INC. (NXGL) had Cash and Cash Equivalents of $938.00 thousand as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2025-11-12
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $938.00K.
- 2024-12-31: Cash and Cash Equivalents, at Carrying Value $1.81M.
- 2024-09-30: Cash and Cash Equivalents, at Carrying Value $1.06M.
- 2023-12-31: Cash and Cash Equivalents, at Carrying Value $2.70M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2025-09-30 | $938.00K 10-Q · filed 2025-11-12 |
| 2024-12-31 | $1.81M 10-Q · filed 2025-11-12 |
| 2024-09-30 | $1.06M 10-Q · filed 2025-11-12 |
| 2023-12-31 | $2.70M 10-Q · filed 2024-11-13 |
| 2022-09-30 | $1.43M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $4.42M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $10.52M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $13.35M 10-Q · filed 2022-11-08 |
| 2021-09-30 | $1.25M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $382.00K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $1.07M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $32.00K 10-K · filed 2022-03-21 |
| 2020-09-30 | $157.00K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $233.00K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $220.00K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $261.00K 10-K · filed 2021-03-31 |
| 2019-09-30 | $88.00K 10-Q · filed 2020-01-28 |
| 2019-06-30 | $186.00K 10-Q · filed 2019-09-09 |
| 2018-12-31 | $0.00 10-K/A · filed 2020-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |